IncobotulinumtoxinA for Glabellar Frown Lines in Chinese Subjects: A Randomized, Double-blind, Active-Controlled Phase-3 Study
Yan Wu(Guangzhou University of Chinese Medicine), Li Bi(Peking University), Susanna Roll(MerLion Pharma (Germany)), Thorin L. Geister(MerLion Pharma (Germany)), Michael Makara(Duke Medical Center), Gudrun Klein(MerLion Pharma (Germany))
Cited by 4
Related Papers
The P300 and reward valence, magnitude, and expectancy in outcome evaluation
|Brain Research|2009|474
Updating the diagnosis, classification and assessment of rosacea: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel
|British Journal of Dermatology|2016|287
Global Aesthetics Consensus
|Plastic & Reconstructive Surgery|2016|249
Exposure of male mice to two kinds of organophosphate flame retardants (OPFRs) induced oxidative stress and endocrine disruption
|Environmental Toxicology and Pharmacology|2015|174
Rosacea treatment update: recommendations from the global <scp>ROS</scp> acea <scp>CO</scp> nsensus ( <scp>ROSCO</scp> ) panel
|British Journal of Dermatology|2016|156